Privi Speciality Chemicals Limited — Important, 14-06-2025: General Updates

Privi Speciality Chemicals has announced a board meeting to review the financial results for the quarter and half-year. The company has shelved a previously approved Rs 1,000 Cr qualified institutions placement, citing improved performance and healthy cash flows. It approved a scheme to merge related party Privi Fine Sciences and subsidiary Privi Biotechnologies, aiming to boost operational efficiency and expand its green science and biotech portfolio. The merger is expected to be value accretive and enhance market competitiveness without any cash outflow.